In the United Kingdom, the National Institute for Health and Care Excellence (NICE) has provided guidance to the National Health Service (NHS) regarding cost effective use of novel AOMs, prioritizing patients with higher BMI and related complications, thereby limiting access for those with less complicated obesity (171)
Introduction In the evolving landscape of metabolic health management, two compounds have gained significant attention for their therapeutic potential: Glucagon-Like Peptide-1 (GLP-1) receptor agonists and glutathione
Poor sleep may compound the muscle-loss risk on GLP-1 therapy Kion Sleep here Consider a blood panel To rule out iron deficiency, B12 depletion, or vitamin D insufficiency as contributing factors A Note on Rate of Weight Loss Very rapid weight loss on GLP-1 medications (more than 11.5 pounds per week on average) significantly increases the proportion of lean mass lost
Take our free self-assessment to see where your hormones stand
Lipo C with B12 is a lipotropic compound, a blend of methionine, inositol, choline, and vitamin B12 that supports the livers ability to process and transport fat